The expression of major histocompatibility complex (MHC) class I antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV)

[1]  L. Mucke,et al.  Viral persistence in neurons explained by lack of major histocompatibility class I expression. , 1991, Science.

[2]  F. Bloom,et al.  High resolution in situ hybridization to determine the cellular distribution of lymphocytic choriomeningitis virus RNA in the tissues of persistently infected mice: relevance to arenavirus disease and mechanisms of viral persistence. , 1991, The Journal of general virology.

[3]  M. Oldstone,et al.  Persistent infection with lymphocytic choriomeningitis virus enhances expression of MHC class I glycoprotein on cultured mouse brain endothelial cells. , 1991, Journal of Immunology.

[4]  M. Oldstone,et al.  Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo. , 1989, Journal of Immunology.

[5]  D. Silberberg,et al.  Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells. , 1988, Journal of Immunology.

[6]  H. Wekerle,et al.  Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. , 1987, The Journal of experimental biology.

[7]  P. Doherty,et al.  The acute inflammatory process in murine lymphocytic choriomeningitis is dependent on Lyt-2+ immune T cells. , 1987, Cellular immunology.

[8]  W. Hickey,et al.  Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Lassmann,et al.  Cellular immune reactivity within the CNS , 1986, Trends in Neurosciences.

[10]  M. Oldstone,et al.  Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system , 1986, Nature.

[11]  W. Hickey,et al.  Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement. , 1986, Journal of immunology.

[12]  D. Silberberg,et al.  Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. , 1986, Science.

[13]  D. Faller,et al.  Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. , 1985, Journal of immunology.

[14]  D. Wilson,et al.  Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes. , 1985, Journal of immunology.

[15]  M. Oldstone,et al.  Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. , 1983, The Journal of general virology.

[16]  J. Levy,et al.  Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes , 1981, The Journal of experimental medicine.

[17]  M. Buchmeier,et al.  Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. , 1981, Virology.

[18]  H. Lemke,et al.  Fine Specificity Analysis with Monoclonal Antibodies of Antigens Controlled by the Major Histocompatibility Complex and by the Qa/TL Region in Mice , 1979, Immunological Reviews.

[19]  M. V. Doyle,et al.  Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections. , 1978, Journal of immunology.

[20]  F. Murphy,et al.  Lymphocytic choriomeningitis: ultrastructural pathology. , 1975, Experimental and molecular pathology.

[21]  R. Zinkernagel,et al.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.

[22]  R. Zinkernagel,et al.  CYTOTOXIC THYMUS-DERIVED LYMPHOCYTES IN CEREBROSPINAL FLUID OF MICE WITH LYMPHOCYTIC CHORIOMENINGITIS , 1973, The Journal of experimental medicine.

[23]  R. Blanden,et al.  Antiviral Action of Immune Lymphocytes in Mice Infected with Lymphocytic Choriomeningitis Virus , 1972, Infection and Immunity.

[24]  N. Nathanson,et al.  Requirement for Θ-Bearing Cells in Lymphocytic Choriomeningitis Virus-induced Central Nervous System Disease , 1972, Nature.

[25]  A. Monjan,et al.  IMMUNOPATHOGENESIS OF ACUTE CENTRAL NERVOUS SYSTEM DISEASE PRODUCED BY LYMPHOCYTIC CHORIOMENINGITIS VIRUS , 1972, The Journal of experimental medicine.

[26]  J. Hotchin,et al.  Lymphocytic choriomeningitis infection of mice as a model for the study of latent virus infection. , 1958, Canadian journal of microbiology.

[27]  M. Oldstone,et al.  Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. , 1986, Nature.

[28]  M. Buchmeier,et al.  Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis. , 1985, British medical bulletin.

[29]  G. Wong,et al.  Inducible expression of H–2 and Ia antigens on brain cells , 1984, Nature.

[30]  F. Lehmann-Grube.  Portraits of viruses: arenaviruses. , 1984, Intervirology.

[31]  N. Bogomolova,et al.  [Chronic viral infections]. , 1984, Klinicheskaia meditsina.

[32]  M. Buchmeier,et al.  Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). , 1983, The American journal of pathology.

[33]  M. Buchmeier,et al.  The virology and immunobiology of lymphocytic choriomeningitis virus infection. , 1980, Advances in immunology.

[34]  R M Zinkernagel,et al.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. , 1979, Advances in immunology.

[35]  R. Zinkernagel,et al.  T-cell-mediated immunopathology in viral infections. , 1974, Transplantation reviews.